Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose gonadotropin treatment is effective for infertility in women with PCOS, leading to high ovulation rates and comparable pregnancy rates with fewer complications.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Hair loss in women not always linked to increased oil production; other factors may be involved.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Finasteride may help some women with hair loss, but better options exist.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

The VEGF +405G allele may increase the risk of PCOS in South Indian women.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Post-finasteride syndrome causes lasting sexual, neurological, and physical side effects in some people after taking finasteride.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.